CSK and cardiac arrhythmia: Specifically, the inhibition of C-terminal Src kinase (CSK) and alterations in the inositol phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, along with possible disruptions in cardiac ion channels, are thought to contribute to the development of arrhythmias and atrial fibrosis (26–30).